Navigation Links
Neurim Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of Piromelatine for the Treatment of Insomnia
Date:2/17/2013

ZURICH, February 18, 2013 /PRNewswire/ --

Neurim Pharmaceuticals announced today positive results from a phase II clinical study evaluating the efficacy and safety of Piromelatine (Neu-P11), a novel investigational multimodal sleep medicine developed for the treatment of patients with primary and co-morbid insomnia. The new results are from a  recent double-blind, randomized, placebo controlled, parallel group, non-confirmatory, sleep-laboratory study. The study evaluated piromelatine compared to placebo in 120 adult primary insomnia patients ages 18 years and older.

Piromelatine 20/50mg treatment for 4 weeks resulted in statistically significant and clinically meaningful improvements relative to placebo in key  polysomnographic (PSG) parameters including Wake After Sleep Onset (WASO) (p=0.02 for both doses) and in particular WASO for the first 6 hours of sleep (WASO-6h) (p=0.0008 and p=0.04 for the 50 mg and 20 mg groups, respectively). Piromelatine 50 mg also improved Sleep Efficiency (SEF) (p=0.02), Total Sleep Time (TST) (p=0.02), Total Time Awake (TTA) (p=0.01) and time in NREM sleep (p=0.028) indicating beneficial effects on sleep maintenance. Subjective improvements relative to placebo in quality of sleep and total sleep time measured by the Pittsburg Sleep Quality Questionnaire (PSQI) were also observed, confirming the PSG findings. Piromelatine enhanced NREM sleep EEG delta power and significantly reduced beta power (p<0.05). The decrease in EEG beta activity, a marker of cortical arousal, is a physiological surrogate marker of the efficacy of Piromelatine in sleep maintenance. Piromelatine was generally safe and well tolerated, had no detrimental effects on next-day psychomotor performance (as assessed by the Digit Symbol Substitution Test (DSST)) for any dose group and no deleterious effects on sleep structure and architecture.

"Piromelatine demonstrates a good potential for the treatm
'/>"/>

SOURCE Neurim Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Tocagen Inc. today announced that ... free survival at six months for recurrent high grade ... FC, compared to published benchmarks. HGG includes glioblastoma, the ... The data were delivered in an oral presentation at the ... of the Society for Neuro-Oncology (SNO) by Tim ...
(Date:11/17/2014)... CHARLOTTESVILLE, Va. , Nov. 17, 2014 HemoShear ... present at the 6th annual Partnering for Cures ... New York City . Marshall Summar , MD, ... Brian Wamhoff , PhD, Vice President of R&D and Co-founder ... of new rare disease treatments in less time and with ...
(Date:11/17/2014)... , Nov. 17, 2014   Wilson Therapeutics ... the start of a Phase 2 clinical study to ... WTX101 in Wilson Disease, a rare genetic disorder and ... to process copper. "We are delighted to ... patients as a next step in the development program ...
Breaking Medicine Technology:Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 2Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 4Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 5HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 2HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 3HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 4Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3
... Oct. 8 The Health Industry Distributors Association (HIDA) ... educating key audiences about the value of medical products ... are supported by medical products delivered by a distributor, ... in supporting healthcare and making it more efficient," said ...
... , IRVINE, Calif., Oct. 8 ... treatments for aortic disorders, acknowledged today that it has become ... in the United States District Court alleging that Endologix infringes ... and Chief Executive Officer, said, "We have just become aware ...
Cached Medicine Technology:Endologix Comments on Alleged Patent Infringement 2
(Date:11/18/2014)... Nov. 17, 2014 (HealthDay News) -- Hispanic women who,ve had ... a certain type of heart trouble than those who,ve had ... team of researchers led by Shivani Aggarwal of Wake Forest ... and older, from Chicago, Miami, New York City and San ... at least six children. A type of heart trouble ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... people on the verge of burning out are more likely ... suffering from so-called vital exhaustion -- a toxic combination of ... risk of developing heart disease, researchers report. "In our ... And I think, when that stress is left unchecked for ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... Sierra Leone who became infected with Ebola in his native country ... Martin Salia had arrived Saturday at Nebraska Medical Center in Omaha. ... hospital in Sierra Leone,s capital city of Freetown. Sierra Leone, ... been ravaged by the Ebola outbreak that began last spring and ...
(Date:11/18/2014)... Randy Dotinga HealthDay Reporter ... use smartphone apps that help them track how many calories ... people who used a popular one after their doctor recommended ... conclusively debunk the idea of using such apps as weight-loss ... and their level of motivation varied, the researchers noted, and ...
(Date:11/17/2014)... 17, 2014 Vernon Brewer, Founder and President ... last two weeks and saw firsthand the devastating holocaust that ... in Iraq and Syria. , “‘Holocaust’ is not a term ... killed or driven thousands of Christians and members of other ... situation is desperate. As ISIS expands, they continue to ...
Breaking Medicine News(10 mins):Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3
... Bertalan Mesko, medical blogger and health 2.0 consultant, ... medical and scientific videos and animations. This list ... best quality. Some of the sites are created for ... focusing on health issues, while others were designed primarily ...
... who,d been tormented, , , FRIDAY, May 8 (HealthDay News) ... younger are more likely than others their age to ... report. , Their study involved 6,437 youths, who averaged ... provided regular updates about the youngsters, health and development ...
... CDC report shows 11 cases of similar strain since 2005 ... puzzled as to the roots of the swine flu outbreak currently ... U.S. Centers for Disease Control and Prevention and released online Thursday ... 11 cases of infection with a swine flu virus similar to ...
... May 8 The majority of uninsured American families ... an employer cannot afford to buy health insurance, according ... Research and Quality.Some experts have suggested that because 23.8 ... have access to employer-based health insurance have incomes above ...
... WINNIPEG, May 8 /PRNewswire/ - Kevin McGarry, Chairman of ... Systems), announces the appointment of Dr. Niels Erik Hansen ... to the appointment of Dr Hansen, Mr. McGarry held ... Chief Executive Officer and stewarded its evolution from a ...
... Pregnancy (MiP) Consortium, led by the Liverpool School of ... European and Developing Countries Clinical Trials Partnership (EDCTP) to ... The three grant recipients the Liverpool School ... Research in Spain and the Prince Leopold Institute of ...
Cached Medicine News:Health News:Bullying Seems to Affect Kids Years Later 2Health News:Scientists Still Baffled About Origins of Swine Flu 2Health News:Scientists Still Baffled About Origins of Swine Flu 3Health News:Scientists Still Baffled About Origins of Swine Flu 4Health News:New Study Finds Fewer Families Can Afford Health Insurance 2Health News:MiP Consortium awarded €11 million by EDCTP 2Health News:MiP Consortium awarded €11 million by EDCTP 3
... the market leader in digital mobile ... experience and advanced technologies into the ... entry, the MiniView 6800. This new ... the workstation components of our full-sized ...
Lightweight & portable, compact station. Accurate and speedy measurement, auto-shot function, AI measuring function, focusing indicator....
... The SmartPLUG from Medennium is ... the "punctum" or tear duct, and ... is designed to fit a range ... flexible thermosensitive acrylic material, SmartPLUG adjusts ...
Provides quick freezing and quick defrosting. Lightweight probe tips have high conductivity silver. Useful for Cataract, Retinal Detachment, Glaucoma and Intra-vitreal surgery. Includes either one ca...
Medicine Products: